ONWARD Medical is a medical technology company developing therapies to restore movement, function, and independence for people with spinal cord injury (SCI). Its core technical domains are neurostimulation systems and brain-computer interface (BCI) technologies. The company is headquartered in Eindhoven, the Netherlands.
The company's product portfolio includes the ARC Therapy platforms. ARC-EX is an FDA-cleared non-invasive spinal cord stimulation system, while ARC-IM is an investigational implantable system. These products have collectively earned 10 FDA Breakthrough Device Designation awards. The company also develops brain-computer interface technologies as part of its neurotechnology portfolio.
ONWARD Medical holds nearly 400 patents, either issued or pending. Recent capital raises have provided over EUR 40 million for commercial expansion and continued technology development. The company brings together a multidisciplinary team of scientists, engineers, and physicians.
